| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. | Director | Common Stock | 13.1K | $421K | $32.03 | Jun 14, 2024 | Direct |
| Arcturus Therapeutics Holdings Inc. | Director | Deferred Stock Units | 0 | $0 | $32.03 | Jun 14, 2024 | Direct |
| Arcturus Therapeutics Holdings Inc. | Director | Stock option (right to buy) | 15K | Jun 9, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics Holdings Inc. | Jun 9, 2025 | 1 | $0 | 4 | Jun 11, 2025 | Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Jun 14, 2024 | 3 | $0 | 4 | Jun 18, 2024 | Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Aug 1, 2023 | 2 | $0 | 4 | Aug 3, 2023 | Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| ARCT | Arcturus Therapeutics Holdings Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |